Profiling the secretion of soluble mediators by end stage osteoarthritis synovial tissue explants reveals a reduced responsiveness to an inflammatory trigger.

OBJECTIVE: Evidence is accumulating that synovial tissue plays an active role in osteoarthritis (OA), however, exact understanding of its contribution is lacking. In order to further elucidate its role in the OA process, we aimed to identify the secretion pattern of soluble mediators by synovial tis...

Full description

Bibliographic Details
Main Authors: Lobke M Gierman, Benno van El, Frits van der Ham, Angela Koudijs, Reinout Stoop, Jan H Verheijen, Margreet Kloppenburg, Gerjo J V M van Osch, Vedrana Stojanovic-Susulic, Tom W J Huizinga, Anne-Marie Zuurmond
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3643929?pdf=render
_version_ 1828287973737627648
author Lobke M Gierman
Benno van El
Frits van der Ham
Angela Koudijs
Reinout Stoop
Jan H Verheijen
Margreet Kloppenburg
Gerjo J V M van Osch
Vedrana Stojanovic-Susulic
Tom W J Huizinga
Anne-Marie Zuurmond
author_facet Lobke M Gierman
Benno van El
Frits van der Ham
Angela Koudijs
Reinout Stoop
Jan H Verheijen
Margreet Kloppenburg
Gerjo J V M van Osch
Vedrana Stojanovic-Susulic
Tom W J Huizinga
Anne-Marie Zuurmond
author_sort Lobke M Gierman
collection DOAJ
description OBJECTIVE: Evidence is accumulating that synovial tissue plays an active role in osteoarthritis (OA), however, exact understanding of its contribution is lacking. In order to further elucidate its role in the OA process, we aimed to identify the secretion pattern of soluble mediators by synovial tissue and to assess its ability to initiate cartilage degeneration. METHODS: Synovial tissue explants (STEs) obtained from donors without history of OA (n = 8) or from end stage OA patients (n = 16) were cultured alone or together with bovine cartilage explants in the absence or presence of IL-1α. The secretion of 48 soluble mediators was measured and the effect on glycosaminoglycan (GAG) release and matrix metalloproteinase (MMP) activity was determined. RESULTS: Normal and OA STEs secreted comparable levels of almost all measured soluble mediators. However, in the presence of IL-1α these mediators were less secreted by OA than by normal STEs of which 15 differed significantly (p<0.01). No effect of normal or OA STEs on GAG release from the cartilage explants was observed, and no differences in MMP activity between OA and normal STEs were detected. CONCLUSIONS: Unexpectedly, a comparable secretion profile of soluble mediators was found for OA and normal STEs while the reduced responsiveness of OA STEs to an inflammatory trigger indicates a different state of this tissue in OA patients. The effects could be the result of prolonged exposure to an inflammatory environment in OA development. Further understanding of the pro-inflammatory and inflammation resolving mechanisms during disease progression in synovial tissue may provide valuable targets for therapy in the future.
first_indexed 2024-04-13T09:56:02Z
format Article
id doaj.art-cb24ac37455648b7995b492bcc1307e5
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-13T09:56:02Z
publishDate 2013-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-cb24ac37455648b7995b492bcc1307e52022-12-22T02:51:23ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0185e6263410.1371/journal.pone.0062634Profiling the secretion of soluble mediators by end stage osteoarthritis synovial tissue explants reveals a reduced responsiveness to an inflammatory trigger.Lobke M GiermanBenno van ElFrits van der HamAngela KoudijsReinout StoopJan H VerheijenMargreet KloppenburgGerjo J V M van OschVedrana Stojanovic-SusulicTom W J HuizingaAnne-Marie ZuurmondOBJECTIVE: Evidence is accumulating that synovial tissue plays an active role in osteoarthritis (OA), however, exact understanding of its contribution is lacking. In order to further elucidate its role in the OA process, we aimed to identify the secretion pattern of soluble mediators by synovial tissue and to assess its ability to initiate cartilage degeneration. METHODS: Synovial tissue explants (STEs) obtained from donors without history of OA (n = 8) or from end stage OA patients (n = 16) were cultured alone or together with bovine cartilage explants in the absence or presence of IL-1α. The secretion of 48 soluble mediators was measured and the effect on glycosaminoglycan (GAG) release and matrix metalloproteinase (MMP) activity was determined. RESULTS: Normal and OA STEs secreted comparable levels of almost all measured soluble mediators. However, in the presence of IL-1α these mediators were less secreted by OA than by normal STEs of which 15 differed significantly (p<0.01). No effect of normal or OA STEs on GAG release from the cartilage explants was observed, and no differences in MMP activity between OA and normal STEs were detected. CONCLUSIONS: Unexpectedly, a comparable secretion profile of soluble mediators was found for OA and normal STEs while the reduced responsiveness of OA STEs to an inflammatory trigger indicates a different state of this tissue in OA patients. The effects could be the result of prolonged exposure to an inflammatory environment in OA development. Further understanding of the pro-inflammatory and inflammation resolving mechanisms during disease progression in synovial tissue may provide valuable targets for therapy in the future.http://europepmc.org/articles/PMC3643929?pdf=render
spellingShingle Lobke M Gierman
Benno van El
Frits van der Ham
Angela Koudijs
Reinout Stoop
Jan H Verheijen
Margreet Kloppenburg
Gerjo J V M van Osch
Vedrana Stojanovic-Susulic
Tom W J Huizinga
Anne-Marie Zuurmond
Profiling the secretion of soluble mediators by end stage osteoarthritis synovial tissue explants reveals a reduced responsiveness to an inflammatory trigger.
PLoS ONE
title Profiling the secretion of soluble mediators by end stage osteoarthritis synovial tissue explants reveals a reduced responsiveness to an inflammatory trigger.
title_full Profiling the secretion of soluble mediators by end stage osteoarthritis synovial tissue explants reveals a reduced responsiveness to an inflammatory trigger.
title_fullStr Profiling the secretion of soluble mediators by end stage osteoarthritis synovial tissue explants reveals a reduced responsiveness to an inflammatory trigger.
title_full_unstemmed Profiling the secretion of soluble mediators by end stage osteoarthritis synovial tissue explants reveals a reduced responsiveness to an inflammatory trigger.
title_short Profiling the secretion of soluble mediators by end stage osteoarthritis synovial tissue explants reveals a reduced responsiveness to an inflammatory trigger.
title_sort profiling the secretion of soluble mediators by end stage osteoarthritis synovial tissue explants reveals a reduced responsiveness to an inflammatory trigger
url http://europepmc.org/articles/PMC3643929?pdf=render
work_keys_str_mv AT lobkemgierman profilingthesecretionofsolublemediatorsbyendstageosteoarthritissynovialtissueexplantsrevealsareducedresponsivenesstoaninflammatorytrigger
AT bennovanel profilingthesecretionofsolublemediatorsbyendstageosteoarthritissynovialtissueexplantsrevealsareducedresponsivenesstoaninflammatorytrigger
AT fritsvanderham profilingthesecretionofsolublemediatorsbyendstageosteoarthritissynovialtissueexplantsrevealsareducedresponsivenesstoaninflammatorytrigger
AT angelakoudijs profilingthesecretionofsolublemediatorsbyendstageosteoarthritissynovialtissueexplantsrevealsareducedresponsivenesstoaninflammatorytrigger
AT reinoutstoop profilingthesecretionofsolublemediatorsbyendstageosteoarthritissynovialtissueexplantsrevealsareducedresponsivenesstoaninflammatorytrigger
AT janhverheijen profilingthesecretionofsolublemediatorsbyendstageosteoarthritissynovialtissueexplantsrevealsareducedresponsivenesstoaninflammatorytrigger
AT margreetkloppenburg profilingthesecretionofsolublemediatorsbyendstageosteoarthritissynovialtissueexplantsrevealsareducedresponsivenesstoaninflammatorytrigger
AT gerjojvmvanosch profilingthesecretionofsolublemediatorsbyendstageosteoarthritissynovialtissueexplantsrevealsareducedresponsivenesstoaninflammatorytrigger
AT vedranastojanovicsusulic profilingthesecretionofsolublemediatorsbyendstageosteoarthritissynovialtissueexplantsrevealsareducedresponsivenesstoaninflammatorytrigger
AT tomwjhuizinga profilingthesecretionofsolublemediatorsbyendstageosteoarthritissynovialtissueexplantsrevealsareducedresponsivenesstoaninflammatorytrigger
AT annemariezuurmond profilingthesecretionofsolublemediatorsbyendstageosteoarthritissynovialtissueexplantsrevealsareducedresponsivenesstoaninflammatorytrigger